Fundraising Fox

Health Technology Holding (HTH)

Pre-Seed–Series B · 2 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Hands-on early-stage life‑science investor and advisor offering deep, science-driven due diligence (PoC, MoA, animal models, KOL/clinician interviews) and access to pharma, corporate partnerships and stakeholder networks.

Invests inAI & Machine LearningBiotechHealthtechMedical DevicesCanadaEuropeIsraelUnited States
Stage
Pre-Seed–Series B
Check
$500K – $1M
Leads rounds
Follows

Team · 2 people

from the firm's website
Michelle Gaiotto· Managing Principalin

Michelle Gaiotto pairs statistical training with $1B+ cross‑asset investment experience, offering a quantitative edge as a CEO who leads financings and serves on boards of medical companies globally from Italy.

Marco Gullà· Investment Associatein

Marco Gullà combines a Master's in Medical Biotechnology with dual roles spanning corporate innovation strategy and early-stage venture capital evaluation, mentoring university-linked programs across Europe and judging medtech pitch competitions.

Frequently asked questions

What stage does Health Technology Holding (HTH) invest at?
Health Technology Holding (HTH) invests at the Pre-Seed, Seed, Series A, Series B stages.
What is Health Technology Holding (HTH)'s typical check size?
Health Technology Holding (HTH) typically writes checks of $500K – $1M.
What sectors does Health Technology Holding (HTH) focus on?
Health Technology Holding (HTH) focuses on AI & Machine Learning, Biotech, Healthtech, Medical Devices.
Does Health Technology Holding (HTH) lead rounds?
Health Technology Holding (HTH) typically participates in rounds rather than leading them.

Featured in lists